Results 131 to 140 of about 148,211 (310)

Influenza and Human Papillomavirus Vaccine Utilisation in Vulnerable Urban Youth in Edmonton, Alberta, Canada

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT Introduction This project explores influenza and human papillomavirus (HPV) vaccine utilisation among a multi‐ethnic group of youth (aged 11–23 years) in Edmonton, Alberta, Canada. Method Using a cross‐sectional design and purposive sampling, influenza vaccine utilisation over 3 years was assessed via questionnaire.
Sarah Deck, Se Lim Jang, Rachel Harris, Fariba Kolahdooz, Moutasem Zakkar, Sangita Sharma   +5 more
wiley   +1 more source

SPATIAL ANALYSIS FOR MICROPLANNING TO ADDRESS IMMUNIZATION INEQUALITIES IN INDONESIA

Jurnal Administrasi Kesehatan Indonesia
Background: To achieve high and equitable immunization coverage, it is important to understand the access and utilization barriers, as well as the influencing determinants among population groups.
Erni Astutik, Arief Hargono, Kurnia Dwi Artanti, Atik Choirul Hidajah, Zida Husnina, Siti Shofiya Novita Sari, R. Vensya Sitohang, Asik Surya, Ratna Budi Hapsari, Marta Feletto   +9 more
doaj   +1 more source

Cost‐effectiveness of risk‐stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage

International Journal of Cancer, EarlyView.
What's New? Effective cervical cancer prevention centers around screening and testing for human papillomavirus (HPV) infection. With birth cohorts of HPV‐vaccinated women now reaching screening‐eligible ages, however, the best means to maintaining cost‐effective cervical cancer screening is unclear.
Tiago M. de Carvalho, Johannes Berkhof, Johannes A. Bogaards   +2 more
wiley   +1 more source

A guideline for economic evaluations of vaccines and immunization programs in China. [PDF]

Hum Vaccin Immunother, 2022
Fang H, Chen C, Fang Y, He X, Hou Z, Jiang M, Jiang Y, Li S, Liu Y, Sui B, Sun Q, Wu J, Xu T, Yang J, Yin Z, Ying X, Yuan B, Zheng H, Zheng Y.   +18 more
europepmc   +1 more source

On the Determinants of Mortality Reductions in the Developing World [PDF]

This paper presents and critically discusses a vast array of evidence on the determinants of mortality reductions in developing countries. We argue that increases in life expectancy between 1960 and 2000 were largely independent from improvements in ...
Rodrigo R. Soares
core  

mRNA Vaccination for Treating Allergy by Modulating Allergen‐Specific Immunity

iLABMED, EarlyView.
This News and Views article discusses the rationale for anti‐allergy vaccine development using a lipid nanoparticle‐mRNA platform. The authors provide additional evidence that supports the potential of using the mRNA approach to combat allergic diseases.
Kun Guo, Lijing Liu, Mingyun Shen, Karin Loré, Ang Lin   +4 more
wiley   +1 more source

Evaluation study of the National Immunization Program Information System

Revista Brasileira de Enfermagem
Objective: To carry out the National Immunization Program Information System (SIPNI) accessability assessment (EA), considering the description of the intervention, the elaboration of the theoretical-logical model and the identification of the evaluative
Brener Santos Silva, Hiago Victor Coelho, Ricardo Bezerra Cavalcante, Valéria Conceição de Oliveira, Eliete Albano de Azevedo Guimarães   +4 more
doaj   +1 more source

Ampk regulates IgD expression but not energy stress with B cell activation. [PDF]

, 2019
Ampk is an energy gatekeeper that responds to decreases in ATP by inhibiting energy-consuming anabolic processes and promoting energy-generating catabolic processes.
Ahsan, Fasih M, Braas, Daniel, Graeber, Thomas G, Hong, Jason S, Kim, Diane NH, Minasyan, Aspram, Teitell, Michael A, Ten Hoeve, Johanna, Waters, Lynnea R, Zangle, Thomas A   +9 more
core   +1 more source

2013 Annual Letter from Bill Gates [PDF]

, 2013
In previous annual letters, Gates focused on the power of innovation to reduce hunger, poverty, and disease. But any innovation -- whether it's a new vaccine or an improved seed -- can't have an impact unless it reaches the people who will benefit from ...
Bill Gates
core  

Respiratory Syncytial Virus Under the Lens of Structure: From Prefusion Stabilization to Next‐Generation Immunotherapies

iNew Medicine, EarlyView.
This illustration integrates key concepts covered in the review, including high‐risk populations, viral structure, host entry factors, the replication cycle, and licensed antibody‐based prevention strategies. ABSTRACT Respiratory syncytial virus (RSV) is a negative‐sense RNA virus belonging to the genus Orthopneumovirus within the family Pneumoviridae.
Zekai Cheng, Qianqian Wang, Jiachen Zhang, Sandra Chiu   +3 more
wiley   +1 more source